Novo Nordisk Gross Profit 1988-2025 | NVO
Novo Nordisk annual/quarterly gross profit history and growth rate from 1988 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Novo Nordisk gross profit for the quarter ending June 30, 2025 was $9.736B, a 16.76% increase year-over-year.
- Novo Nordisk gross profit for the twelve months ending June 30, 2025 was $38.179B, a 20.65% increase year-over-year.
- Novo Nordisk annual gross profit for 2024 was $35.653B, a 24.96% increase from 2023.
- Novo Nordisk annual gross profit for 2023 was $28.531B, a 35.68% increase from 2022.
- Novo Nordisk annual gross profit for 2022 was $21.028B, a 12.83% increase from 2021.
| Novo Nordisk Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $35,653 |
| 2023 | $28,531 |
| 2022 | $21,028 |
| 2021 | $18,637 |
| 2020 | $16,241 |
| 2019 | $15,280 |
| 2018 | $14,405 |
| 2017 | $14,288 |
| 2016 | $14,057 |
| 2015 | $13,651 |
| 2014 | $13,238 |
| 2013 | $12,366 |
| 2012 | $11,156 |
| 2011 | $10,047 |
| 2010 | $8,754 |
| 2009 | $7,612 |
| 2008 | |